Paul Fleming
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Ubiquitin and proteasome pathways 10
- Porphyrin Metabolism and Disorders 3
- Protein Degradation and Inhibitors 2
- Oncology 14
- Peptidase Inhibition and Analysis 6
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Lawrence R. Dick (6 shared papers)Christopher Blackburn (5 shared papers)Kazumi Shiosaki (2 shared papers)Shirling Tsai (2 shared papers)Bing Guan (2 shared papers)Paul Hales (7 shared papers)Christopher Tsu (7 shared papers)Khristofer Garcia (5 shared papers)
- Journals
- Journal of the American Chemical Society (3 papers)Cancer Research (2 papers)Journal of Inorganic Biochemistry (2 papers)Molecular Cancer Therapeutics (2 papers)International Immunopharmacology (1 paper)
- Partner nations
- United StatesNorwayJapan
In The Last Decade
Paul Fleming
22 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Hematology 243
- Oncology 417
- Molecular Biology 926
- Organic Chemistry 396
- Genetics 57
Countries citing papers authored by Paul Fleming
This map shows the geographic impact of Paul Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Fleming more than expected).
Fields of papers citing papers by Paul Fleming
This network shows the impact of papers produced by Paul Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Fleming. The network helps show where Paul Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 408 | |
| 2 | 1998 | 309 | |
| 3 | 2010 | 233 | |
| 4 | 2010 | 128 | |
| 5 | 1993 | 53 | |
| 6 | 2010 | 39 | |
| 7 | 1994 | 34 | |
| 8 | 2011 | 32 | |
| 9 | 1994 | 28 | |
| 10 | 2018 | 25 | |
| 11 | 1991 | 24 | |
| 12 | 1998 | 12 | |
| 13 | 2016 | 10 | |
| 14 | 2016 | 10 | |
| 15 | 2012 | 9 | |
| 16 | 1994 | 5 | |
| 17 | 2018 | 5 | |
| 18 | 1998 | 2 | |
| 19 | 2015 | 2 | |
| 20 | 2002 | 2 |
About Paul Fleming
Paul Fleming is a scholar working on Molecular Biology, Oncology, Pharmacology, Rheumatology and Organic Chemistry, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Peptidase Inhibition and Analysis (6 papers), Cancer Treatment and Pharmacology (4 papers), Folate and B Vitamins Research (3 papers), Cancer-related Molecular Pathways (3 papers), Porphyrin Metabolism and Disorders (3 papers), Microbial Natural Products and Biosynthesis (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (243 citations), Oncology (417 citations), Molecular Biology (926 citations), Organic Chemistry (396 citations) and Genetics (57 citations). Paul Fleming has collaborated with scholars based in United States, Norway and Japan. Frequent co-authors include Lawrence R. Dick, Christopher Blackburn, Kazumi Shiosaki, Shirling Tsai, Bing Guan, Paul Hales, Christopher Tsu, Khristofer Garcia, Frank J. Bruzzese and Jonathan L. Blank. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research, Journal of Inorganic Biochemistry, Molecular Cancer Therapeutics and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.